Crescent Biopharma Down Over 16%, On Pace for Largest Percent Decrease Since July 2024 -- Data Talk

Dow Jones
05/01

Crescent Biopharma, Inc. $(CBIO)$ is currently at $18.77, down $3.60 or 16.09%

 

--Would be lowest close since April 13, 2026, when it closed at $17.99

--On pace for largest percent decrease since July 25, 2024, when it fell 24.2%

--Currently down three of the past four days

--Down 24.31% this week; worst weekly performance since the week ending Jan. 30, 2026, when it fell 25.08%

--Up 58.26% year-to-date

--Down 99.26% from its all-time closing high of $2535.00 on Feb. 15, 2018

--Down 28.25% from 52 weeks ago (May 2, 2025), when it closed at $26.16

--Down 31.67% from its 52-week closing high of $27.47 on May 5, 2025

--Up 109.96% from its 52-week closing low of $8.94 on Feb. 13, 2026

--Traded as low as $14.91; lowest intraday level since March 30, 2026, when it hit $14.25

--Down 33.35% at today's intraday low; largest intraday percent decrease since July 25, 2024, when it fell as much as 34.84%

 

All data as of 11:54:40 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

May 01, 2026 11:58 ET (15:58 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10